News/Companies/PIII

PIII News

P3 Health Partners Announces Second Quarter 2025 Results

HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial results for the second quarter ended June 30, 2025. “Our core business continues to strengthen as we execute on our $130 million EBITDA improvement plan,” said Aric Coffman, CEO of P3. “While we faced prior period headwinds, we've successfully managed medical cost trends to remain flat while imp

August 14, 2025Earnings

P3 Health Partners Affirms FY2025 Sales Guidance of $1.35B-$1.50B vs $1.41B Est

May 15, 2025

P3 Health Partners Q1 EPS $(6.28) Up From $(7.86) YoY, Sales $373.23M Beat $362.07M Estimate

May 15, 2025

What to Expect from P3 Health Partners's Earnings

May 14, 2025

Lake Street Maintains Buy on P3 Health Partners, Lowers Price Target to $20

April 21, 2025

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

April 11, 2025

P3 Health Partners Sees FY25 Revenue $1.35B-$1.50B Vs $1.401B Est.

March 27, 2025

P3 Health Partners Q4 2024 GAAP EPS $(0.36) Misses $(0.09) Estimate, Sales $370.686M Miss $378.056M Estimate

March 27, 2025

Earnings Preview For P3 Health Partners

March 26, 2025

P3 Health Targeting Profitability In 2025, With Initial Revenue Guidance For The Year Of $1.350B-$1.5B And Adjusted EBITDA Of ($35)M-$5M.

February 13, 2025

TD Cowen Maintains Hold on P3 Health Partners, Lowers Price Target to $0.25

November 20, 2024

P3 Arizona Announces New Medical Clinic In Cochise County, Arizona

September 13, 2022